Chronic wasting disease in Europe: characterisation of genetic susceptibility and strain diversity
dc.contributor.advisor
Houston, Fiona
dc.contributor.advisor
Diack, Abigail
dc.contributor.author
Robinson, Amy Louise
dc.date.accessioned
2022-03-01T12:37:08Z
dc.date.available
2022-03-01T12:37:08Z
dc.date.issued
2022-03-01
dc.description.abstract
Chronic wasting disease (CWD) is a prion disease that causes a fatal, progressive
neurodegenerative disorder in cervid species including deer, elk, reindeer and
moose. CWD has become widespread in North America in both wild and farmed
cervid populations; disease control poses significant challenges due to efficient
horizontal transmission and environmental persistence. The recent
identification of CWD affecting reindeer, moose and red deer in Norway and
other Scandinavian countries threatens a similar pattern of spread in European
cervids, impacting the health of wild populations as well as deer farming and
hunting industries. It is widely accepted that prion diseases are associated with
an unusual infectious agent, a misfolded, protease resistant, self-propagating
isoform (PrPSc) of the normal cellular prion protein (PrPC).
Susceptibility is
largely determined by the sequence of the prion protein gene (PRNP). In North
America, PRNP polymorphisms in cervid species have been associated with
reduced susceptibility, altered pathogenesis and the emergence of new CWD
strains.
Understanding CWD in the European context cannot be solely based on North
American evidence due to the differences in cervid species and unknown effects
of novel strains. I aimed to characterise the PRNP polymorphisms in British deer
species and predict their effects on CWD susceptibility using in-vitro assays. I
also aimed to determine if the pathological phenotypic characteristics of
Norwegian and Canadian CWD isolates are maintained in primary passage to
wild-type mice, and if lymphoid replication is an important feature in primary
passage.
To determine the PRNP variation in British cervid species, a large-scale survey
of the six most numerous species of wild deer in the UK was performed,
including red (Cervus elaphus), sika (Cervus nippon), roe (Capreolus capreolus),
fallow (Dama dama), muntjac (Muntiacus reevesii), and Chinese water deer
(Hydropotes inermis), which was compared with two smaller surveys of red deer
from Norway and the Czech Republic. The PRNP gene is well conserved in cervid
species, and we identified low levels of variation in most cervid species,
particularly roe deer, which were identical in all individuals analysed.
Based on
comparison with susceptible North American deer species, it is likely that a high
proportion of the UK deer population would be susceptible at least to the strains
of CWD present in North America. Red deer showed the most PRNP variation,
with five haplotypes identified which varied in frequency depending on
location: the P168S and I247L polymorphisms were only identified in Scottish
and Czech populations, respectively. These novel polymorphisms are not
present in North American cervid populations, and their impact on CWD
susceptibility are unknown.
The effects of PRNP variants on CWD susceptibility may be determined in
naturally infected cervid populations, experimental challenge of cervids, or in
transgenic mice expressing cervid prion proteins. The mechanisms by which
individual amino acid substitutions influence disease susceptibility and
pathogenesis are likely to include modification of epitopes crucial for PrPC
structure, stability, and conversion to PrPSc. These effects may be reproduced
using in-vitro assays that analyse the conversion efficiency of different PrP
protein sequences by PrPSc derived from prion-infected tissues. To test the
misfolding capacity and conversion efficiency of British deer PRNP variants, two
in-vitro assays were developed: a recombinant PrP protein fibrillisation assay
and a cell-lysate protein misfolding amplification assay (PMCA) using RK13 cells
transfected with red deer PRNP sequences as substrate.
Analysis of Norwegian CWD isolates and their transmission into rodent models
has provided preliminary evidence that there are several different strains
present in reindeer and moose which differ from those in North America.
The
gold standard test for strain differentiation is bioassay and assessment of the
differences in heritable phenotypes in a new host species. As part of ongoing
strain-typing studies of Norwegian CWD, I describe the primary passage of
isolates from the first Norwegian reindeer and moose cases, as well as two
Canadian CWD isolates, in well-defined panels of wild-type mice (VM, C57BL/6J
and RIII) which have been used extensively in previous strain-typing
experiments. Evidence of transmission was examined in both brain and
lymphoid tissues using a combination of immunohistochemistry, western blot
and RT-QuIC amplification. Low transmission rates were observed for the
transmission of natural CWD cases from Norway and Canada, however
transmission rates were high for an experimental H95+ strain isolate with 72%
of mice showing evidence of infection, 40% of which exhibited clinical signs.
The work presented here represents some of the first steps towards
understanding PRNP variation in European cervid populations, developing
methods for the assessment of novel PRNP polymorphisms, and the
characterisation of European strain diversity. It is unclear if the efforts made to
contain CWD in Norway will be successful, and further research is urgently
required to inform risk assessments and control strategies. The origins of CWD
remain unknown, and it is possible that further novel instances of CWD will be
identified in different cervid species and geographic locations. The emergence of
CWD in Europe poses a considerable challenge, the extent of which will critically
depend on the susceptibility of cervid populations and the characterisation of
new prion strains that may differ in their ability to transmit to other species
including livestock and man.
en
dc.identifier.uri
https://hdl.handle.net/1842/38646
dc.identifier.uri
http://dx.doi.org/10.7488/era/1909
dc.language.iso
en
en
dc.publisher
The University of Edinburgh
en
dc.relation.hasversion
Robinson AL, Williamson H, Güere ME, Tharaldsen H, Baker K, Smith SL, Pérez Espona S, Krojerová-Prokešová J, Pemberton JM, Goldmann W, Houston F (2019) Variation in the prion protein gene (PRNP) sequence of wild deer in Great Britain and mainland Europe. Vet Res 50:59 . doi: 10.1186/s13567-019-0675-6
en
dc.subject
chronic wasting disease
en
dc.subject
CWD
en
dc.subject
wild deer health
en
dc.subject
prion diseases
en
dc.subject
PRNP variation
en
dc.subject
PrP variants
en
dc.subject
red deer
en
dc.subject
susceptibility of deer populations
en
dc.title
Chronic wasting disease in Europe: characterisation of genetic susceptibility and strain diversity
en
dc.type
Thesis or Dissertation
en
dc.type.qualificationlevel
Doctoral
en
dc.type.qualificationname
PhD Doctor of Philosophy
en
Files
Original bundle
1 - 1 of 1
- Name:
- Robinson2021.pdf
- Size:
- 8.57 MB
- Format:
- Adobe Portable Document Format
- Description:
This item appears in the following Collection(s)

